HOMEOutlinePrevious Show ReportExhibitor's Presentation

Download 2018
Application Form

Co-located with:

Get Our Newsletter:

Keynote SpeechOrganizer's Seminar / Sponsor's Seminar / Luncheon Seminar2012 Exhibitor's Presentation / Academic Seeds Presentation / Global PartneringOpen Innovation Zone Short Presentations

Exhibitor's Presentation

E : English session

I : Interpretation

J : Japanese session

Oct. 14 (Wed.)

  Seminar Stage A Seminar Stage B Seminar Stage C Seminar Stage D
10:00

10:20-10:50

HEC Pharm GroupE

HEC Pharm Presentation

10:20-10:50

【medU-net】
St. Marianna University School of Medicine

New anti-inflammatory agent based on a new mechanism

10:20-10:50

Chuo University

In silico drug discovery pipeline using FAMS and chooseLD

 
 
 
 
 
 
       
       
11:00

11:00-11:30

【medU-net】
Gifu University

 

11:00-12:00

Organization for Small & Medium Enterprises and Regional Innovation

 

PharmaCo-Cell

in vitro model of the Blood-brain barrier for permeability assay

Genome Pharmaceuticals Institute

GeneFrontier

Unique Solutions for Innovative Biologics

Oncomics

Towards a new biomarker discovery

Hamamatsu Pharma Research

Knee osteoarthritis (OA) and chemotherapy-induced peripheral neuropathy (CINP) in NHP

Adan

SnG

Novel Dual-Pore Silica Particle Enabling High Adsorption/ Separation/ Controlled Release/Catalysis Activities

Pico-device

Skin gas would be a key senseing gas for the health care monitaring

Jitsubo

A process innovation in peptide therapeutic business

JFE Techno-Research

11:00-11:30

Tohoku University

 

11:00-11:30

HitGenE

Lead Discovery for Challenging Targets using Hitgen's Encoded Library Technology

11:30-12:00

【medU-net】
Gifu University

 

11:30-12:00

Tohoku University

 

 
 

11:40-12:10

National Research Program for Biopharmaceuticals, NRPB/Development Center For Biotechnology, DCB E

National Research Program for Biopharmaceuticals

12:00      
 

12:05-12:20

PsychoGenicsE

PsychoGenics Technology Platforms

 

12:10-12:40

CzechInvestE

Life science in the Czech Republic

   
   
 

12:20-12:50

KBI Biopharma E

Analytical Methods for Therapeutic Protein Release, Stability, Characterization, and Comparability

 
   

12:30-13:00

【medU-net】
University of Toyama

beta-carboline derivatives as eliminate agent of nutrient starvation-resistance of pancreatic cancer.

 

12:35-13:05

Domainex E

IKK epsilon inhibitors with activity in inflammatory disease: COPD, psoriasis and Lupus

 

12:45-13:00

CurisE

Curis Corporate Presentation

 
 
13:00  

13:00-13:30

【medU-net】
University of Toyama

Development of anti-diabatic agents that suppress pancreatic β cell death and NLRP3 inflammasome activation

13:00-13:30

【medU-net】
TOKAI UNIVERSITY

 

   

13:10-13:40

Organization for Small & Medium Enterprises and Regional Innovation

TBA

Introduction of simple genetic test strip, STH-PAS

A-CLIP Institute

Antibody drug for vasculitis and inflammation diseases

GlobalEngineering

AFI

 

13:15-13:45

Team Finland HealthE

Innovative LifeScience technology in Finland today with new solutions

   
   
 

13:40-14:10

Hiroshima University

Continuous monitoring of insulin secretion from cultured living cells

13:40-13:55

TOKYO UNIVERSITY OF SCIENCE

Translational enhancer that promotes protein biosynthesis and leads to enriched grain production

13:45-14:00

BioKierE

A Novel Treatment for Diabetes

 
 

13:55-14:10

TOKYO UNIVERSITY OF SCIENCE

13:55-14:25

Fujifilm Diosynth BiotechnologiesE I

A 2020 vision for mAbs - Innovation for success

14:00  
 
     
     
 

14:20-14:35

Abzena E

Abzena enables the development of better biopharmaceuticals

14:20-14:50

University of Tsukuba

 

   
   
   

14:35-15:05

Jellagen E I

Jellyfish Collagen: a novel source of biomaterials

   
   
 

14:50-15:20

Kumamoto University

 

 
   
15:00

15:00-16:30

BioJapan 2015
Special Seminar J

 

15:00-15:30

【medU-net】
Nagasaki Agricultural and Forestry Technical Development Center

Development of the functional foods (mixed fermented teas) manufactured by using agricultural products in Nagasaki

 
 

15:15-15:45

Osaka Municipal Technical Research Institute

 

 
 

15:30-16:00

Tottori University

Novel cell-penetrating peptide "Poly-histidine"

 
 

15:40-16:10

【medU-net】
Hamamatsu University School of Medicine

Development of phospholipid-base anti-cancer drug targetting for gastric cancer with no side effects

 
 

15:55-16:25

THE University of Tokyo / Greennetwork

 

16:00  
 

16:10-16:40

【medU-net】
Nagasaki University

Development of drug delivery peptide

 
 

16:20-16:50

ERATO Asano Active Enzyme Molecule Project (Toyama Prefectural University)

 

 
 

16:30-17:00

Saitama Medical University

Development of a universal influenza vaccine utilizing liposome-coupled antigens

 
   
   
     
     

Oct. 15 (Thu.)

  Seminar Stage A Seminar Stage B Seminar Stage C Seminar Stage D
10:00

10:20-10:50

Ohu University School of Pharmaceutical Sciences

Development of a novel diagnostic system for periodontitis

10:20-10:50

The University of Electro-Communications, MAKI Lab.

The Luminescent substrate for the observation of the living body to the deep

10:20-10:50

True Cell Simulations (Translational Research Initiative, The University of Tokyo)

Qualifying Drug Discovery by Cell Simulation

10:20-11:20

Kanagawa Prefectural Government International Business DivisionE

Kanagawa Leading Biotech Companies

10:20-10:25

Welcome Speech

10:25-10:35

SCIVAX Life SciencesE

Advantages of 3D cell culture for cell based assay

10:35-10:45

Biomolecule Analysis Group, Medical ProteoScope CompanyE

Proteomics expertise for the solutions of various problems in bioscience and medicine

10:45-10:55

BayBioImagingE

Contract molecular imaging services

10:55-11:05

GenomembraneE

Transporters: Important tool for the development of new drugs

11:05-11:15

GlycoTechnicaE

The advent of innovative technologies in regenerative medicine and bio-technology based drugs

     

10:55-11:25

Tokyo University of Pharmacy and Life Sciences

 

NEDO

10:55-11:10

MCBI

 

11:10-11:25

Department of Molecular and Cellular Pharmacology, Pharmacogenomics and Pharmacoinformatics, Mie University Graduate School of Medicine

 

11:25-11:40

TWO CELLS

 

11:40-11:55

IDEAQUEST

 

10:55-11:25

Ehime University
(Protein Island Matsuyama)

Cell-free technology accelerates protein science and drug discovery.

11:00
 
   

11:25-12:25

Wallonia Foreign Trade-Investment AgencyE

【Innovative technologies in Life Science from Wallonia, Belgium】- Delphi Genetics, Eurogentec, it4ip and MasTHerCell

11:30-12:00

Pharmacogenomics Mie University Graduate School of Medicine

Next Generation Zebrafish-Based Personalized Oncology

AIST

11:30-11:45

Biotechnology Research Institute for Drug Discovery

Analytical technology development of glycosylated membrane proteins for drug target discovery

11:45-12:00

Biomedical Research Institute

Pluripotent functions of neuronal growth factor in health and disease

12:00-12:15

Biomedical Research Institute

Rapid DNA methylation assesment by immunochemical determination

12:15-12:30

Health Research Institute

Point of Care Testing Chip Using Paper, Film and Tape

 
12:00  

12:00-12:30

【medU-net】
Shiga University of Medical Science

 

 
 
 
 
   
 

12:30-13:00

【medU-net】
Shiga University of Medical Science

 

 

12:30-13:00

QUEBEC: PARTNER TO PROSPER E

Externalizing Pharmaceutical R&D - Opportunities in Quebec and brief overview of the Canadian pharmaceutical legal framework

   
 

12:40-13:10

Holland BioE

Christal TherapeuticsE

CriPec® Nanomedicines for Superior Therapeutic Performance

Dyadic Netherlands E

Turning waste streams into raw materials

TNO Pharma E

Shared Research Opportunities at TNO.

MercachemJ

Collaboration Research on Casein Kinase 1-d inhibitor

 
 
 
13:00

13:00-13:10

Okayama University

Overview of Okayama University

   
   

13:10-13:30

Okayama University

Dual roles of Compound K

   

13:10-13:40

Chemicals Evaluation and Research Institute, Japan

New development: The method to evaluate theraputic antibody's activity by using stable effecter cell lines

   

13:20-13:50

Tokyo Institute of Technology

Regenerative medicine and drug discovery using ES/iPS cells

13:20-13:50

Bio Business Award Japan Executive Committee/
Tokushima University

 

13:30-13:50

Okayama University

Histidine Rich Glycoprotein as a novel prognostic marker in sepsis

 

13:45-16:15

EU-Japan Centre for Industrial Cooperation

  • 3B Pharmaceuticals
    E I

    From Hit to Clinic - Peptide Drug Discovery at 3B Pharmaceuticals
  • Berlin Partner - HealthCapitalE I
    HealthCapital Berlin - Where the heart beats!
  • BioTurku®E I
    Innovative LifeScience technology in Finland today with new solutions
  • Bio-XtalJ
    Discovery of functional antibody targetting GPCRs; proof of concept and applications
  • Cell MedicaE I
    Bringing a cellular therapy to the market
  • High Force Research
    E I

    High Force Research: Partner of choice for Chemical Development and Small Scale GMP Production
  • LIPOPHARMA THERAPEUTICSE I
    Minerval: a novel clinical-stage SMS activator with game-changing potential in glioma
  • MaSTherCellE I
    Manufacturing and developing cell therapy products
  • MEDICEN PARIS REGIONE I
    MEDICEN PARIS REGION, a key actor to access the Paris Region life sciences' ecosystem
  • MercachemE I
    CDK8 INHIBITORS with Long Residence Time emerging from a Retro-Design Approach: New Opportunities for Cancer Treatment
  • Metabolomic DiscoveriesE I
    Kenkodo - Personalized Metabolomics Research
  • Myelo Therapeutics
    E I

    Myelo001 - a novel small molecule for the treatment of Chemotherapy-induced Myelosuppression
  • OXELTISE I
    Services for new chemical entities (NCE) discovery and optimization.
  • PharmacoideaE I
    Hung(a)ry for a new idea? Meet the Pharmacoidea!
  • RemembraneE I
    Membrane lipidomics: a game changer in cell culturing
  • Serravalle - European Patent AttorneyE I
    How to improve European Patent Protection affordably.
  • TissUseE I
    The Multi-Organ-Chip platform: a novel tool for predictive substance testing in vitro
  • VenusRoses LabsolutionsE I
    Youth Elixir recognized from Centuries - Bulgarian Rose Oil
  • Xendo/VigilexE I
    Xendo/Vigilex, a trusted partner to support you with Pharmacovigilance, Regulatory Affairs, Quality- and Data Management.

13:50-14:10

Okayama University

Okayama Medical Inovation Center (OMIC) and Frontier Studies of Molecular Imaging

13:50-14:20

Tokyo Institute of Technology

Engineering of PEG for manipulation of biological molecules

 
 
14:00

14:00-16:00

Biotechnology Cluster Bavaria, Germany (BioM Biotech Cluster Development )E

The Biotechnology Industry in Bavaria (Germany)

  • Ascenion
  • Boeters & Lieck
  • cfm Oskar Tropitzsch
  • Coriolis Pharma Research
  • FGK Clinical Research
  • Gams Wellness
  • Hyglos
  • Iris Biotech
  • LEUKOCARE
  • NDA Regulatory Service
  • PRIAXON
  • Proteros Biostructures
  • synlab pharma institute formerly INTERLAB central lab services

14:10-14:30

Okayama University

Mouse models of cancer for effective personalised immunotherapy

14:20-14:50

Tokyo Institute of Technology

Somatic gain-of-function mutations in deubiquitinase USP8 in pituitary tumors causing Cushing's disease

14:30-14:50

Okayama University

Cancer Immunotherapy by metformin-induced reversion of exhausted T cells

14:50-15:10

Okayama University

A study of Cancer Stem Cells using iPS cells and prospects for therapies

14:50-15:20

Tokyo Institute of Technology

Metabolic pathway for human gut microbiome

15:00
 

15:15-15:45

Hiroshima University

 

 
 

15:30-16:30

IHI / IHI Prant Engineering

 

 

15:50-16:20

Original BioMedicalsE

Innovative Drug Delivery Technologies and Radiation Protection Drug

16:00  

16:05-16:35

Kyoto University / Matsunami Research Park

Using biobank of healthy individuals toward preemptive medicine and R/D of new medical technology for the healthcare needs of the future.

 
 

16:20-16:50

NIKI GLASSEI

 

 
   
     
     
     

Oct. 16 (Fri.)

  Seminar Stage A Seminar Stage B Seminar Stage C Seminar Stage D
10:00

10:20-10:50

The University of Electro-Communications, MAKI Lab.

The Luminescent substrate for the observation of the living body to the deep

10:20-10:50

【medU-net】
Kawasaki Medical School

Diagnostic tool for asbestos exposure and malignant mesothelioma using peripheral blood regarding immunological effects of asbestos.

10:20-10:50

Yokohama City University

 

10:20-10:50

【med-Unet】
Tokyo Medical and Dental University

 

   

10:50-11:20

Yokohama City University

 

 
     
11:00  

11:00-11:30

【medU-net】
Ochanomizu University

Radiation measurement with little organic waste fluid; experimental and management of radiation contamination

11:00-11:30

【medU-net】
Tokyo Metropolitan Institute of Medical Science

 

 
 
 
   
   

11:30-12:00

Waseda University

Development of Functional foods regulating circadian clock system

 

11:30-12:00

Nihon University Business, Research and Intellectual Property Center

Development of novel donor cells derived from mature adipocytes for regenerative medicine

 
   

11:40-12:10

Faculty of Medicine, Fukuoka UniversityE

The high-sensitive allergy test (HiSAT): a rapid, screening and prediction method of allergy before or after drug administration

11:40-12:10

Kagoshima University

 

12:00  

12:00-12:30

Nihon University Business, Research and Intellectual Property Center

Cell-based therapy using dedifferentiated fat (DFAT) cells

 

12:10-13:10

Canadian Embassy

Replicel Life SciencesE

Developing Cell Therapies in Japan as a Foreign Company

Caprion E

Direct Identification of Tumor Neo-antigens for Personalised Cancer Immunotherapy

Ottawa Hospital Research InstituteE

Oncolytic Virus Vaccines: A New Paradigm in Cancer Immunotherapy

 

12:10-12:40

Kagoshima University

Production of Cloned Miniature Pigs Expressing High Levels of Human Apolipoprotein(a) in Plasma

 
 
 

12:30-13:00

Enterprise LithuaniaE

Lithuania - a place where new trends emerge

 
 
   
   
   
   
13:00  

13:00-13:15

ImmunovoE

A novel Immunotherapeutic Approach to Angiogenesis Inhibition: Immunovo's IAS

13:00-14:00

Scandinavian PavilionE

Innovations in pharma and biotech from the Cluster in Sweden and Denmark

 
   

13:15-13:45

National Institute of Genetics

Generation of human conditional mutants by use of the auxin-inducible degron technology

13:15-13:45

University of Fukui

Expected roles of rs-fMRI and genetic variation in autism spectrum disorder: diagnostic aid and the prediction of treatment efficacy

 
 
 

AIST

13:30-13:50

Robotic Biology Institute

 

13:50-14:10

Lifesem

Development of new atmospheric holder for the biological specimens to scanning electron microscopy

14:10-14:30

jTAS

Portable system for high-speed DNA quantification

13:45-14:15

National Institute of Genetics

Bioinformatics and Bio-Resources of National Institute of Genetics

13:45-14:15

University of Fukui

 

14:00  
 

14:10-14:40

Asterand Bioscience E

The Importance of Human Tissues for Validating Biomarkers in Drug Discovery

14:15-14:45

National Institute of Genetics

 

 
 

14:25-14:55

Nagoya UNIV, Advanced Characterization. Nanotechnology Platform

 

 
 

14:40-15:10

Kumamoto University

 

 
   
 

14:50-15:20

Tottori Industrial Promotion Organization Tottori Bio-Frontier

14:55-15:25

【medU-net】
SAPPORO MEDICAL UNIVERSITY

Novel agent and method to optimize cell functions of MSCs for therapeutic effect of diabetic nephropathy

 
15:00  

15:05-15:35

FUKUSHIMA MEDICAL UNIVERSITY

 

 
 

15:20-15:50

【medU-net】
Nagasaki University

Disease-modifying drugs targeting new action sites for Alzheimer’s disease

 
   
   

15:35-16:05

Bruker Daltonics

Overcoming Hurdles in Mono isotope mass measurements for mAbs

   
   

15:45-16:15

UBIC MEDICAL

 

 
   
   
16:00    
     
     

TOPへ戻る

| Sitemap |

© 2017-2018 JTB Communication Design, Inc. All rights reserved.